Advances in the development of an early detection kit for bowel cancer

September 25, 2012
DNA microarray slide before use. Photograph: UPM.

Rubén Armañanzas and Pedro Larrañaga, researchers of the Computational Intelligence Group at the Universidad Politécnica de Madrid's Facultad de Informática have used advanced statistical and data mining techniques to filter information about the activity of over 22,000 genes and have managed to separate tumoural from non-tumoural samples with a precision of 94.45%.

This is the UPM's contribution to a joint effort among several Spanish institutions to assemble a genetic test for early detection. The goal of the study is to develop a low-cost device integrating biomarker measurement and mathematical models.

At present, detection is primarily based on the result of biopsies of polyps identified during a colonoscopy. However, this is a highly invasive technique that often comes too late.

The study started with the analysis of the genetic activity of over 22,000 genes simultaneously using . All this information was filtered using advanced statistical and high-dimensional .

This led to the identification of a small subset of genes that behaved differently in tumoural and non-tumoural samples. A classifier or diagnostic predictor can be built by combining the expression patterns using complex mathematical models.

94.45% precision

Based on the gene panel, known in the technical jargon as biomarkers, the mathematical models are able to classify a new set of tumoural or non-tumoural samples with a precision of 94.45%.

As mentioned earlier, the final goal of the study is to be able to develop a low-cost device integrating the measurement of the biomarker panel and mathematical models. Its use in clinical practice could be helpful for early bowel , while at the same time reducing costs and inconvenience to patients.

The project kicked off in 2005 and has been developed in several phases. It has involved patient recruitment and informed consent, DNA microarray-based laboratory testing, computational analysis using machine learning techniques and validation.

The results have been published in BMC Cancer. Despite the promising results, population studies are now required to further validate the findings. These studies are now under way and are expected to return new results in the coming years.

Explore further: Gene expression changes in nasal cells may help identify lung cancer in earliest stages

More information: Garcia-Bilbao, A; Armananzas, R; Ispizua, Z; Calvo, B; Alonso-Varona, A; Inza, I; Larranaga, P; Lopez-Vivanco, G; Suarez-Merino, B; Betanzos, M. Identification of a biomarker panel for colorectal cancer diagnosis, BMC CANCER, 12 10.1186/1471-2407-12-43 JAN 26 2012

Related Stories

Gene expression changes in nasal cells may help identify lung cancer in earliest stages

May 15, 2011
A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest – and most treatable – stages, according to a study conducted by researchers ...

Potential for earlier diagnosis of ovarian cancer

January 25, 2012
(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.